Abstract
No public abstract is available from the verified source records.
Annabelle F. Rowland, Isson T. Tayidi, Gerald B. Lee
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Assessing diagnostic performance
10.1056/evidra2300232 · 2024
Food allergy: a practice parameter
2006
Elimination diets in Eczema—A cautionary tale
10.1016/j.jaip.2015.10.009 · 2016
Evolving interpretation of screening and diagnostic tests in allergy
10.1016/j.jaip.2021.05.018 · 2021
Unresolved referenced work
1989
Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children
10.1111/all.12530 · 2015
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
10.1016/j.waojou.2019.100080 · 2020
In vivo methods for the study and diagnosis of allergy
2020
Diagnosing peanut allergy with skin prick and specific IgE testing
10.1016/j.jaci.2005.02.038 · 2005
Wheat allergy: a double-blind, placebo-controlled study in adults
10.1016/j.jaci.2005.10.014 · 2006
EAACI guidelines on the diagnosis of IgE-mediated food allergy
10.1111/all.15902 · 2023
Improving diagnostic accuracy in food allergy
10.1016/j.jaip.2020.09.037 · 2021
Laboratory tests for allergic and immunodeficiency diseases
2020
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
10.1111/all.15939 · 2024
Allergen-specific IgE is a stronger predictor of remission following peanut oral immunotherapy than age in children aged 1-10 years
10.1111/all.16451 · 2025
Clinical significance of immunoglobulin E
2020
EAACI molecular allergology user's guide 2.0
2023
Diagnostic accuracy, risk assessment, and cost-effectiveness of component-resolved diagnostics for food allergy: a systematic review
10.1111/all.13399 · 2018
Novel bead-based epitope assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy
10.1038/s41598-019-54868-7 · 2019
Accurate and reproducible diagnosis of peanut allergy using epitope mapping
10.1111/all.14905 · 2021
Accuracy of bead-based epitope assay testing for peanut allergy diagnosis: real-world pediatric population study
10.1016/j.anai.2025.02.010 · 2025
Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope-specific IgE antibody profiling
10.1111/all.15477 · 2022
The basophil activation test is the Most accurate test in predicting allergic reactions to baked and fresh cow's milk during oral food challenges
10.1111/all.16675 · 2025
Basophil activation test: mechanisms and considerations for use in clinical trials and clinical practice
10.1111/all.14747 · 2021
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy
10.1016/j.jaci.2007.11.026 · 2008
Influence of omalizumab on allergen-specific IgE in patients with adult asthma
10.1159/000442668 · 2015
Unresolved referenced work
Kept as external metadata until matched
Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis
2024
Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: a real-life multicentre study (BIONIGE)
10.1002/clt2.12143 · 2022
Extrafollicular IgD+ B cells generate IgE antibody secreting cells in the nasal mucosa
10.1038/s41385-021-00410-w · 2021
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients
2022
Tralokinumab treatment in adult atopic dermatitis patients: 28-week evaluation of clinical effectiveness, safety, serum proteins and total IgE levels
10.1111/all.16414 · 2024
Diagnostics of allergic rhinitis under dupilumab therapy
10.1007/s00405-024-08700-2 · 2024
Food allergy clinical course in children and adolescents treated with dupilumab for atopic dermatitis
10.1016/j.anai.2025.07.023 · 2025
Efficacy and safety of dupilumab in children with peanut allergy: a multicenter, open-label, phase II study
10.1111/all.16404 · 2025
Tezepelumab in patients with allergic and eosinophilic asthma
10.1111/all.15986 · 2023
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial
10.1016/j.jaci.2022.08.029 · 2023
Remibrutinib (LOU064): a selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial
10.1111/cts.13005 · 2021
Pharmacodynamic analysis of BTK inhibition in patients with chronic lymphocytic leukemia treated with acalabrutinib
10.1158/1078-0432.ccr-19-3505 · 2020
No clinically meaningful impact of remibrutinib on immunoglobulin levels or infections in chronic spontaneous urticaria
10.1016/j.anai.2024.08.317 · 2024
Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks
10.1016/j.jaci.2023.10.007 · doi-reference